Cimini Andrea, Ricci Francesca, Pugliese Luca, Chiaravalloti Agostino, Schillaci Orazio, Floris Roberto
Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.
Department of Nuclear Medicine IRCSS, Neuromed, Pozzilli, Italy.
Indian J Nucl Med. 2019 Jan-Mar;34(1):45-47. doi: 10.4103/ijnm.IJNM_101_18.
An 80-year-old male with a previous history of thymoma and kidney cancer underwent a F fluorodeoxyglucose (FDG) positron emission tomography (PET)/contrast-enhanced computed tomography (CT) scan: two pulmonary nodules were discovered, both characterized by an increased glucose uptake. Of them, only one showed mild contrast enhancement. Both nodules were surgically resected: the first nodule was a benign meningioma and the second one was a malignant meningioma. This case study shows that malignancy of meningioma in the lung is not correlated with F FDG uptake and the contrast enhancement, thus suggesting that PET/CT may represent a suboptimal imaging modality for the evaluation of these lesions.
一名80岁男性,既往有胸腺瘤和肾癌病史,接受了18F氟脱氧葡萄糖(FDG)正电子发射断层扫描(PET)/对比增强计算机断层扫描(CT):发现两个肺结节,均表现为葡萄糖摄取增加。其中只有一个显示轻度对比增强。两个结节均接受手术切除:第一个结节是良性脑膜瘤,第二个是恶性脑膜瘤。本病例研究表明,肺内脑膜瘤的恶性程度与18F FDG摄取及对比增强无关,因此提示PET/CT可能不是评估这些病变的最佳影像学检查方法。